Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Dextromethorphan hydrobromide
JNTL Consumer Health I (Ireland) Limited
R05DA; R05DA09
Dextromethorphan hydrobromide
Syrup
Opium alkaloids and derivatives; dextromethorphan
Marketed
1994-11-10
PACKAGE LEAFLET: INFORMATION FOR THE USER Non-Drowsy Dry Coughs Syrup DEXTROMETHORPHAN HYDROBROMIDE 7.5 MG/ 5 ML READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side-effects, talk to your doctor or pharmacist. This includes any possible side-effects not listed in this leaflet. See section 4. - You must talk to a doctor if you do not feel better or if you feel worse after 5 days. WHAT IS IN THIS LEAFLET 1. What Benylin Non-Drowsy Dry Coughs Syrup is and what it is used for 2. What you need to know before you use Benylin Non- Drowsy Dry Coughs Syrup 3. How to use Benylin Non-Drowsy Dry Coughs Syrup 4. Possible side-effects 5. How to store Benylin Non-Drowsy Dry Coughs Syrup 6. Contents of the pack and other information 1 WHAT BENYLIN NON-DROWSY DRY COUGHS SYRUP IS AND WHAT IT IS USED FOR Benylin Non-Drowsy Dry Coughs Syrup is a medicine which is used to help relieve dry, irritating coughs. The liquid contains dextromethorphan hydrobromide which is an antitussive to help stop persistent coughing. The medicine is for use in adults and children aged 12 years and over. 2 WHAT YOU NEED TO KNOW BEFORE YOU USE BENYLIN NON- DROWSY DRY COUGHS SYRUP This medicine is suitable for most people but a few people should not use it. If you are in any doubt, talk to your doctor or pharmacist. This medicine can lead to dependence. Therefore the treatment should be of short duration. DO NOT USE BENYLIN NON-DROWSY DRY COUGHS SYRUP… If you have ever had a BAD REACTION to dextromethorphan or any of the other ingredients. If you suffer from LUNG DISEASE. If you are taking, or have taken in the last two weeks, DRUGS FOR DEPRESSION known as Monoamine Oxidase Inhibitors (MAOIs). If you are taking selective serotonin re-uptake inhi Read the complete document
Health Products Regulatory Authority 28 March 2024 CRN00DGV2 Page 1 of 7 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Benylin Non-Drowsy Dry Coughs, Syrup Dextromethorphan hydrobromide 7.5mg/5ml 2 QUALITATIVE AND QUANTITATIVE COMPOSITION BENYLIN Non-Drowsy Dry Coughs, Syrup contains dextromethorphan hydrobromide 7.5 mg in each 5 ml. Each 5 ml of BENYLIN Non-Drowsy Dry Coughs, Syrup also contains: Sorbitol solution (70%) E420 325 mg Sucrose 1625 mg Glucose 2380 mg Sodium 4.4 mg Ethanol 236 mg Sodium benzoate 25 mg Propylene glycol 2.7 mg Invert sugar 6.7mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Syrup A clear amber coloured syrup with a characteristic smell of peaches. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS BENYLIN Non-Drowsy Dry Coughs, Syrup is indicated for the relief of non-productive irritating cough. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION ADULTS AND CHILDREN 12 YEARS AND OVER: Oral. 15 mg (10 ml syrup) 3-4 times a day. Maximum daily dose: 40 ml syrup CHILDREN UNDER 12 YEARS: This product is contraindicated in children under the age of 12 years (See section 4.3). HEPATIC DYSFUNCTION Due to the extensive hepatic metabolism of dextromethorphan, caution should be exercised in the presence of hepatic impairment (See sections 4.4 and 5.2). 4.3 CONTRAINDICATIONS This product is contraindicated in individuals with known hypersensitivity to dextromethorphan or to any of the excipients listed in section 6.1. Dextromethorphan should not be used in patients taking monoamine oxidase inhibitors (MAOIs), or within 14 days of stopping MAOI treatment (see section 4.5). There is a risk of serotonin syndrome with the concomitant use of dextromethorphan and MAOIs and the concomitant use of these medications may cause a rise in blood pressure and / or hypertensive crisis (see section 4.5). This product is contraindicated in patients taking serotonin reuptake inhibitors (SSRIs, see section 4.5). Health Products Regulatory Authority 28 March 2024 CRN00DGV2 Page 2 o Read the complete document